Contingency Screening using Noninvasive Prenatal Test for the Detection of Trisomy 21
Aashima Arora, Rashmi Bagga, Japleen Kaur
Citation Information :
Arora A, Bagga R, Kaur J. Contingency Screening using Noninvasive Prenatal Test for the Detection of Trisomy 21. J Postgrad Med Edu Res 2017; 51 (4):207-208.
Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011 Jan;31(1):7-15.
Accuracy of noninvasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 2016 Jan;6(1):e010002.
First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2015 Jan;45(1):42-47.
Combined first trimester screen or noninvasive prenatal testing or both. Singapore Med J 2015 Jan;56(1):1-3.
Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins. J Clin Med 2014 Jun;3(3):679-692.
Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result. Ultrasound Obstet Gynecol 2016 Jun;47(6):698-704.
